Rare diseases
Investigational molecules
Locations
Thialfweg 44, 8441 PW Heerenveen, The Netherlands
Frisius MC in Heerenveen, The Netherlands specialises in clinical trials of conditions such as Renal cell carcinoma, Chronic lymphocytic leukaemia, Chronic lymphocytic leukaemia refractory, Chronic lymphocytic leukaemia recurrent, and other specialisations. This site conducts important research.
The Dept of Oncology at Frisius MC concentrates on chronic lymphocytic leukemia and small lymphocytic lymphoma, seeking safer dosing options and improved long‑term outcomes for patients with relapsed or refractory disease.
Current studies evaluate alternative cabozantinib dosing schedules to maintain drug exposure while minimizing side effects, and they compare continued venetoclax therapy versus treatment interruption to assess impact on progression‑free survival.
Research in solid‑tumor oncology focuses on renal cell carcinoma, exploring novel combinations and treatment durations to enhance patient survival.
Ongoing trials aim to determine whether extending venetoclax after rituximab improves progression‑free survival, providing valuable data for future therapeutic strategies.
More sites in HeerenveenThe Netherlands
Clinical trials currently enrolling participants at this site.
The NetherlandsThe NetherlandsMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
